Groupe la Francaise’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-60
Closed -$1.39K – 480
2025
Q3
$1.39K Buy
+60
New +$1.52K ﹤0.01% 729

Other funds holding ARKG

Groupe la Francaise's ARKG Position: Q4 2025 in Review

Groupe la Francaise sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 60 shares — an estimated $1.39K sold.

Groupe la Francaise first reported a position in ARKG in Q3 2025 and held it in 1 quarter. The position peaked at $1.39K in Q3 2025. 241 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • Groupe la Francaise reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • Groupe la Francaise sold 60 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $1.39K.
  • Groupe la Francaise first reported a position in ARK Genomic Revolution ETF in Q3 2025 and held it in 1 quarter.
  • Groupe la Francaise's ARK Genomic Revolution ETF position peaked at $1.39K in Q3 2025.
  • 241 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.